COLLPLANT BIOTECH. IS-01 (CPT) — Net Asset Quality Index
COLLPLANT BIOTECH. IS-01 (CPT) has a Net Asset Quality Index of 56.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €10.79 Million minus total liabilities of €4.70 Million yields net assets of €6.08 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read COLLPLANT BIOTECH. IS-01 debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
COLLPLANT BIOTECH. IS-01 Net Asset Quality Index Over Time (2021–2025)
This chart shows how COLLPLANT BIOTECH. IS-01's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 56.4%, representing net assets of €6.08 Million against total assets of €10.79 Million EUR. For live market cap and overall valuation, see COLLPLANT BIOTECH. IS-01 market cap and net worth.
Annual Net Asset Quality Index for COLLPLANT BIOTECH. IS-01 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for COLLPLANT BIOTECH. IS-01 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See CPT net asset value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 56.4% | €6.08 Million | €10.79 Million | €4.70 Million | ▼ -15.6 pp |
| 2024 | 72.0% | €13.46 Million | €18.71 Million | €5.25 Million | ▼ -11.1 pp |
| 2023 | 83.0% | €28.34 Million | €34.13 Million | €5.79 Million | ▼ -2.4 pp |
| 2022 | 85.5% | €32.28 Million | €37.77 Million | €5.49 Million | ▼ -2.6 pp |
| 2021 | 88.1% | €45.12 Million | €51.22 Million | €6.10 Million | — |